Skip to main content

Table 5 Comparison of biochemical parameters from baseline to third follow-up

From: Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation

Variables (Units)

Baseline N = 29

First follow-up N = 29

Second follow-up N = 29

Third follow-up N = 29

P value

SGOT (U/L)

 Median (IQR)

41.00 (6.00)

38.00 (5.50)

40.00 (5.50)

41.00 (5.00)

 

 Mean ± SD

41.00 ± 4.29

39.17 ± 6.50

40.76 ± 5.77

42.14 ± 5.66

0.10

SGPT (U/L)

 Median (IQR)

40.00 (4.00)

40.00 (4.00)

41.00 (6.50)

39.00

 

 Mean ± SD

39.90 ± 3.58

40.52 ± 5.21

41.28 ± 5.96

(11.00) 41.62 ± 7.82

0.99

ALP (U/L)

 Median (IQR)

78.00 (12.00)

78.00 (6.50)

78.00 (6.50)

72.00

 

 Mean ± SD

77.69 ± 8.04

79.83 ± 7.79

78.72 ± 6.02

(11.00) 73.62 ± 5.70

0.64

Bilirubin (mg/dL)

 Median (IQR)

1.00 (0.35)

0.90 (0.45)

.90 (0.35)

1.00 (0.40)

0.016

 Mean ± SD

1.06 ± 0.23

0.89 ± 0.26

0.92 ± 0.32

1.01 ± 0.29

Urea (mg/dL)

 Median (IQR)

36.00 (7.00)

35.00 (8.50)

40.00 (6.50)

38.00 (5.50)

 

 Mean ± SD

37.38 ± 3.95

38.48 ± 6.68

39.66 ± 6.61

38.44 ± 5.42

0.82

Creatinine (ng/mL)

 Median (IQR)

0.80 (0.40)

1.00 (0.55)

0.80 (0.40)

0.80 (0.35)

0.98

 Mean ± SD

0.86 ± 0.30

0.94 ± 0.35

0.88 ± 0.36

0.91 ± 0.30

Random blood sugar (mg/dL)

 Median (IQR)

80.00 (11.50)

88.00

89.00 (6.00)

89.00

0.031

 Mean ± SD

85.76 ± 17.16

(10.00) 92.79 ± 18.40

93.00 ± 15.04

(10.00) 92.28 ± 18.50

  1. ALP Alkaline phosphatase, IQR Inter-quartile range, SD standard deviation, SGOT serum glutamic-oxalacetic transaminase, SGPT serum glutamic-pyruvic transaminase
  2. Note: Statistically significant P values have been italicized